Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA <i>MALAT1</i> in breast cancer progression

Background: is overexpressed in more than 20 cancers, including breast cancer and has been shown to function via various mechanisms in a context-dependent manner, in 2D cell lines and mouse models. However, its functional role and therapeutic potential have not been evaluated in clinically relevant patient-derived models. Methods: to study its impact on transcription, alternative splicing, stromal remodeling and metastasis. Results: depletion induced a consistent reduction in macrophage-associated gene signatures and reduced lung metastatic burden. Conclusions: -targeted ASO therapy and establishes PDO-X models as a clinically relevant platform for functional interrogation of TNBC therapies.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-04-03
DOI
https://doi.org/10.64898/2026.04.02.716096
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA MALAT1 in breast cancer progression

Taylor Floyd, Alexey S. Revenko, Disha Aggarwal, John Erby Wilkinson et al.
bioRxiv (Cold Spring Harbor Laboratory)
Cancer-related molecular mechanisms research
article

Patient-derived organoid xenografts reveal the multifaceted role of the lncRNA MALAT1 in breast cancer progression

Taylor Floyd, Alexey S. Revenko, Disha Aggarwal, John Erby Wilkinson, Qing Gao, Kendall Anderson, Sonam Bhatia, Gayatri Arun, Shuchismita R. Satpathy, W. Richard McCombie, Shruti V. Iyer, David L. Spector, Karen Kostroff, Martin Akerman, Melissa Kramer, Payal Naik, Raditya Utama, Sara A Pawlak, Suzanne Russo, James A. Rouse
article en

Abstract

Background: is overexpressed in more than 20 cancers, including breast cancer and has been shown to function via various mechanisms in a context-dependent manner, in 2D cell lines and mouse models. However, its functional role and therapeutic potential have not been evaluated in clinically relevant patient-derived models. Methods: to study its impact on transcription, alternative splicing, stromal remodeling and metastasis. Results: depletion induced a consistent reduction in macrophage-associated gene signatures and reduced lung metastatic burden. Conclusions: -targeted ASO therapy and establishes PDO-X models as a clinically relevant platform for functional interrogation of TNBC therapies.

bioRxiv (Cold Spring Harbor Laboratory)
Northwell Health (US), Long Island University (US), Cold Spring Harbor Laboratory (US), Ionis Pharmaceuticals (United States) (US), Stony Brook University (US)
Cold Spring Harbor Laboratory, Northwell Health, National Institutes of Health, National Cancer Institute
Good health and well-being
Openalex Percentile: Top 26%
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.